Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gynecology

Free Subscription Articles published in Cancer Retrieve available abstracts of 143 articles: HTML format

Single Articles

July 2021
1. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
   Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
   Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
   PubMed     Abstract available
   
   
   
2. NYAKUDARIKA NC, Holschneider CH, Sinno AK
   Universal social needs assessment in gynecologic oncology: An important step toward more informed and targeted care in the public safety net.
   Cancer. 2021 Jul 12. doi: 10.1002/cncr.33761.
   PubMed     Abstract available
   
   
   June 2021
3. PRINTZ C
   Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
   Cancer. 2021;127:1951-1952.
   PubMed    
   
   
   May 2021
4. KIM SR, Tone A, Kim RH, Cesari M, et al
   Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
   Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
   PubMed     Abstract available
   
   
   
5. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
   Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
   Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
   PubMed     Abstract available
   
   
   April 2021
6. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
   Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
   Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
   PubMed     Abstract available
   
   
   
7. CHEN YS, Zhou ZN, Glynn SM, Frey MK, et al
   Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-income women in New York City.
   Cancer. 2021 Apr 26. doi: 10.1002/cncr.33537.
   PubMed     Abstract available
   
   
   
8. URICK ME, Yu EJ, Bell DW
   High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
   Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
   PubMed     Abstract available
   
   
   
9. PRINTZ C
   Lower Cervical Cancer Risk Associated With HPV Vaccine.
   Cancer. 2021;127:1171.
   PubMed    
   
   
   
10. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available
    
    
    
11. MCALPINE JN, Chiu DS, Nout RA, Church DN, et al
    Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33516.
    PubMed     Abstract available
    
    
    March 2021
12. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    PubMed     Abstract available
    
    
    
13. RODRIGUEZ VE, LeBron AMW, Chang J, Bristow RE, et al
    Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Cancer. 2021 Mar 15. doi: 10.1002/cncr.33502.
    PubMed     Abstract available
    
    
    February 2021
14. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    PubMed     Abstract available
    
    
    
15. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available
    
    
    January 2021
16. SELLA T, Partridge AH
    A new look at old problems: Ovarian function suppression in the real world.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33368.
    PubMed    
    
    
    
17. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    PubMed     Abstract available
    
    
    
18. MELIN JM, Seppanen VI, Ylostalo TM, Malila NK, et al
    Risk of induced abortions in childhood cancer survivors.
    Cancer. 2021 Jan 25. doi: 10.1002/cncr.33384.
    PubMed     Abstract available
    
    
    
19. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed     Abstract available
    
    
    December 2020
20. LARA OD, Smith MJ, Wang Y, O'Cearbhaill R, et al
    Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.
    Cancer. 2020 Dec 9. doi: 10.1002/cncr.33335.
    PubMed     Abstract available
    
    
    
21. PRINTZ C
    Screening entire populations for breast and ovarian cancer could prevent millions of cases worldwide, study says.
    Cancer. 2020;126:5007.
    PubMed    
    
    
    
22. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed     Abstract available
    
    
    September 2020
23. GHIRARDI V, Ronsini C, Trozzi R, Di Ilio C, et al
    Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
    Cancer. 2020 Sep 15. doi: 10.1002/cncr.33167.
    PubMed     Abstract available
    
    
    
24. DUSKA LR, Scalici JM, Temkin SM, Schwarz JK, et al
    Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
    Cancer. 2020 Sep 10. doi: 10.1002/cncr.33136.
    PubMed     Abstract available
    
    
    
25. DESSOURCES K, Hari A, Pineda E, Amneus MW, et al
    Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33124.
    PubMed     Abstract available
    
    
    August 2020
26. KIM SR, Tone A, Kim RH, Cesari M, et al
    Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
    Cancer. 2020 Aug 18. doi: 10.1002/cncr.33144.
    PubMed     Abstract available
    
    
    
27. GATTI A, Haruyama R, Elit L, Howard SC, et al
    How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33116.
    PubMed     Abstract available
    
    
    
28. KIM EY, Chang Y, Ahn J, Yun JS, et al
    Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Cancer. 2020 Aug 7. doi: 10.1002/cncr.33138.
    PubMed     Abstract available
    
    
    
29. PRINTZ C
    Experts say that cervical cancer could be eliminated worldwide with screening, human papillomavirus vaccine.
    Cancer. 2020;126:3387.
    PubMed    
    
    
    July 2020
30. LARA OD, O'Cearbhaill RE, Smith MJ, Sutter ME, et al
    COVID-19 outcomes of patients with gynecologic cancer in New York City.
    Cancer. 2020 Jul 30. doi: 10.1002/cncr.33084.
    PubMed     Abstract available
    
    
    
31. CORR BR, Moroney M, Sheeder J, Eckhardt SG, et al
    Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33073.
    PubMed     Abstract available
    
    
    
32. LUTGENDORF SK, Penedo F, Goodheart MJ, Dahmoush L, et al
    Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
    Cancer. 2020 Jul 21. doi: 10.1002/cncr.33060.
    PubMed     Abstract available
    
    
    
33. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    PubMed     Abstract available
    
    
    June 2020
34. PAN K, Chlebowski RT, Mortimer JE, Gunther MJ, et al
    Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Cancer. 2020 Jun 12. doi: 10.1002/cncr.33002.
    PubMed     Abstract available
    
    
    
35. BLESSING AM, Santiago-O'Farrill JM, Mao W, Pang L, et al
    Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32985.
    PubMed     Abstract available
    
    
    
36. WESTRICK AC, Bailey ZD, Schlumbrecht M, Hlaing WM, et al
    Residential segregation and overall survival of women with epithelial ovarian cancer.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32989.
    PubMed     Abstract available
    
    
    May 2020
37. POORT H, de Rooij BH, Uno H, Weng S, et al
    Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.
    Cancer. 2020 May 21. doi: 10.1002/cncr.32927.
    PubMed     Abstract available
    
    
    
38. PRINTZ C
    Research teams unite to develop an early detection test for ovarian cancer.
    Cancer. 2020;126:2113.
    PubMed    
    
    
    April 2020
39. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available
    
    
    
40. 
    The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
    Cancer. 2020 Apr 13. doi: 10.1002/cncr.32867.
    PubMed     Abstract available
    
    
    March 2020
41. CHLEBOWSKI RT, Aragaki AK, Anderson GL, Prentice RL, et al
    Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Cancer. 2020 Mar 25. doi: 10.1002/cncr.32846.
    PubMed     Abstract available
    
    
    
42. RUSSO M, Newell JM, Budurlean L, Houser KR, et al
    Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Cancer. 2020 Mar 18. doi: 10.1002/cncr.32822.
    PubMed     Abstract available
    
    
    
43. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    PubMed     Abstract available
    
    
    February 2020
44. LEE YC, Wang L, Kohn EC, Rubinstein L, et al
    Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32783.
    PubMed     Abstract available
    
    
    
45. PETERSON LL, Park S, Park Y, Colditz GA, et al
    Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32798.
    PubMed     Abstract available
    
    
    
46. PRINTZ C
    Study finds that women with posttraumatic stress disorder have an increased risk of ovarian cancer.
    Cancer. 2020;126:468-469.
    PubMed    
    
    
    
47. PRINTZ C
    Low-income, Asian American women benefit from human papillomavirus self-sampling tests.
    Cancer. 2020;126:469.
    PubMed    
    
    
    
48. VYSOTSKAIA V, Kaseniit KE, Bucheit L, Ready K, et al
    Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Cancer. 2020;126:549-558.
    PubMed     Abstract available
    
    
    January 2020
49. KROENKE CH, Paskett ED, Cene CW, Caan BJ, et al
    Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative.
    Cancer. 2020 Jan 23. doi: 10.1002/cncr.32710.
    PubMed     Abstract available
    
    
    
50. PRINTZ C
    Psychological stress is associated with a higher risk of cervical cancer mortality.
    Cancer. 2020;126:240-241.
    PubMed    
    
    
    
51. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    PubMed     Abstract available
    
    
    December 2019
52. RUBINSTEIN MM, Hyman DM, Caird I, Won H, et al
    Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
    Cancer. 2019 Dec 27. doi: 10.1002/cncr.32677.
    PubMed     Abstract available
    
    
    
53. VERGOTE I, Harter P, Chiva L
    Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer.
    Cancer. 2019;125 Suppl 24:4594-4597.
    PubMed     Abstract available
    
    
    
54. BOOKMAN MA
    Can we predict who lives long with ovarian cancer?
    Cancer. 2019;125 Suppl 24:4578-4581.
    PubMed     Abstract available
    
    
    
55. AREND R, Martinez A, Szul T, Birrer MJ, et al
    Biomarkers in ovarian cancer: To be or not to be.
    Cancer. 2019;125 Suppl 24:4563-4572.
    PubMed     Abstract available
    
    
    
56. LEE JM, Minasian L, Kohn EC
    New strategies in ovarian cancer treatment.
    Cancer. 2019;125 Suppl 24:4623-4629.
    PubMed     Abstract available
    
    
    
57. SEHOULI J, Grabowski JP
    Surgery in recurrent ovarian cancer.
    Cancer. 2019;125 Suppl 24:4598-4601.
    PubMed     Abstract available
    
    
    
58. PIGNATA S, Pisano C, Di Napoli M, Cecere SC, et al
    Treatment of recurrent epithelial ovarian cancer.
    Cancer. 2019;125 Suppl 24:4609-4615.
    PubMed     Abstract available
    
    
    
59. FUJIWARA K, Hasegawa K, Nagao S
    Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy.
    Cancer. 2019;125 Suppl 24:4582-4586.
    PubMed     Abstract available
    
    
    
60. KOOLE SN, van Driel WJ, Sonke GS
    Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
    Cancer. 2019;125 Suppl 24:4587-4593.
    PubMed     Abstract available
    
    
    
61. FRIEDLANDER ML
    Do all patients with recurrent ovarian cancer need systemic therapy?
    Cancer. 2019;125 Suppl 24:4602-4608.
    PubMed     Abstract available
    
    
    
62. GONZALEZ-MARTIN A, Sanchez-Lorenzo L
    Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
    Cancer. 2019;125 Suppl 24:4616-4622.
    PubMed     Abstract available
    
    
    
63. HARTER P, Heitz F, Ataseven B, Schneider S, et al
    How to manage lymph nodes in ovarian cancer.
    Cancer. 2019;125 Suppl 24:4573-4577.
    PubMed     Abstract available
    
    
    November 2019
64. CRAFTON SM, Cohn DE, Llamocca EN, Louden E, et al
    Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
    Cancer. 2019 Nov 27. doi: 10.1002/cncr.32620.
    PubMed     Abstract available
    
    
    
65. YANG WL, Lu Z, Guo J, Fellman BM, et al
    Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32582.
    PubMed     Abstract available
    
    
    
66. SANTIAGO-O'FARRILL JM, Weroha SJ, Hou X, Oberg AL, et al
    Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32600.
    PubMed     Abstract available
    
    
    
67. HUNG P, Deng S, Zahnd WE, Adams SA, et al
    Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
    Cancer. 2019 Nov 8. doi: 10.1002/cncr.32594.
    PubMed     Abstract available
    
    
    
68. PRINTZ C
    Survey of US gynecologic oncologists finds that approximately 64% have experienced sexual harassment.
    Cancer. 2019;125:3691.
    PubMed    
    
    
    October 2019
69. PRINTZ C
    Rethinking a common surgery technique for early cervical cancer: Experts are reconsidering the use of minimally invasive radical hysterectomy as a treatment for early cervical cancer after multiple studies found that patients who undergo the procedure
    Cancer. 2019;125:3485-3487.
    PubMed    
    
    
    
70. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    PubMed    
    
    
    September 2019
71. FICHT AL, Lapidos-Salaiz I, Phelps BR
    Eliminating cervical cancer: Promising developments in primary prevention.
    Cancer. 2019 Sep 26. doi: 10.1002/cncr.32507.
    PubMed    
    
    
    August 2019
72. HAVRILESKY LJ, Yang JC, Lee PS, Secord AA, et al
    Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.
    Cancer. 2019 Aug 27. doi: 10.1002/cncr.32447.
    PubMed     Abstract available
    
    
    
73. MULLINS MA, Peres LC, Alberg AJ, Bandera EV, et al
    Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.
    Cancer. 2019 Aug 15. doi: 10.1002/cncr.32451.
    PubMed     Abstract available
    
    
    July 2019
74. PRINTZ C
    HPV infections most often linked to cervical cancer have declined.
    Cancer. 2019;125:2336-2337.
    PubMed    
    
    
    June 2019
75. STEWART KI, Chasen B, Erwin W, Fleming N, et al
    Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Cancer. 2019 Jun 21. doi: 10.1002/cncr.32329.
    PubMed     Abstract available
    
    
    
76. HOLLIS RL, Churchman M, Michie CO, Rye T, et al
    High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32079.
    PubMed     Abstract available
    
    
    
77. KONDRASHOVA O, Scott CL
    Clarifying the role of EMSY in DNA repair in ovarian cancer.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32135.
    PubMed    
    
    
    May 2019
78. KAHN RM, Gordhandas S, Maddy BP, Baltich Nelson B, et al
    Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Cancer. 2019 May 31. doi: 10.1002/cncr.32203.
    PubMed     Abstract available
    
    
    
79. WASSERMANN J, Gelber SI, Rosenberg SM, Ruddy KJ, et al
    Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32192.
    PubMed     Abstract available
    
    
    
80. PRINTZ C
    Cervical cancer self-sampling tests could improve access.
    Cancer. 2019;125:1583.
    PubMed    
    
    
    
81. PRINTZ C
    Culturally tailored intervention increases HPV vaccination rates among Asian American adolescents.
    Cancer. 2019;125:1583.
    PubMed    
    
    
    
82. PINSKY PF, Black A, Daugherty SE, Hoover R, et al
    Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Cancer. 2019 May 8. doi: 10.1002/cncr.32176.
    PubMed     Abstract available
    
    
    April 2019
83. TSUI J, DeLia D, Stroup AM, Nova J, et al
    Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
    Cancer. 2019;125:1330-1340.
    PubMed     Abstract available
    
    
    
84. LI K, Li Q, Song L, Wang D, et al
    The distribution and prevalence of human papillomavirus in women in mainland China.
    Cancer. 2019;125:1030-1037.
    PubMed     Abstract available
    
    
    March 2019
85. KURNIT KC, Westin SN, Coleman RL
    Microsatellite instability in endometrial cancer: New purpose for an old test.
    Cancer. 2019 Mar 26. doi: 10.1002/cncr.32058.
    PubMed    
    
    
    
86. BAST RC JR, Matulonis UA, Sood AK, Ahmed AA, et al
    Critical Questions in Ovarian Cancer Research and Treatment: Report of an American Association for Cancer Research Special Conference.
    Cancer. 2019 Mar 5. doi: 10.1002/cncr.32004.
    PubMed     Abstract available
    
    
    
87. DE ROOIJ BH, Ezendam NPM, Vos MC, Pijnenborg JMA, et al
    Patients' information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: New insights for tailored delivery.
    Cancer. 2019;125:788-797.
    PubMed     Abstract available
    
    
    February 2019
88. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
    HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
    PubMed     Abstract available
    
    
    
89. LITTLE RF
    Tearing down the false walls to HIV cancer care.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31974.
    PubMed    
    
    
    January 2019
90. FROBERG M, Ostensson E, Belkic K, Ostrbenk A, et al
    Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Cancer. 2019;125:239-248.
    PubMed     Abstract available
    
    
    
91. DING DC, Chen W, Wang JH, Lin SZ, et al
    Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31964.
    PubMed     Abstract available
    
    
    
92. MAO W, Peters HL, Sutton MN, Orozco AF, et al
    The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31935.
    PubMed     Abstract available
    
    
    December 2018
93. TEMKIN SM, Mallen A, Bellavance E, Rubinsak L, et al
    The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
    Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911.
    PubMed     Abstract available
    
    
    
94. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    PubMed    
    
    
    
95. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
    Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
    PubMed     Abstract available
    
    
    
96. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    PubMed    
    
    
    
97. PRINTZ C
    Human papillomavirus testing may detect cervical precancer better than Papanicolaou testing.
    Cancer. 2018;124:4430-4431.
    PubMed    
    
    
    November 2018
98. BINES J, Tevaarwerk AJ
    Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31878.
    PubMed    
    
    
    
99. LAITMAN Y, Michaelson-Cohen R, Levi E, Chen-Shtoyerman R, et al
    Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
    Cancer. 2018 Nov 29. doi: 10.1002/cncr.31842.
    PubMed     Abstract available
    
    
    
100. FREY MK, Kopparam RV, Ni Zhou Z, Fields JC, et al
     Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
     Cancer. 2018 Nov 27. doi: 10.1002/cncr.31856.
     PubMed     Abstract available
     
     
     
101. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
     Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
     Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
     PubMed     Abstract available
     
     
     
102. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
     The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
     Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
     PubMed     Abstract available
     
     
     
103. HARTNETT KP, Mertens AC, Kramer MR, Lash TL, et al
     Pregnancy after cancer: Does timing of conception affect infant health?
     Cancer. 2018 Nov 7. doi: 10.1002/cncr.31732.
     PubMed     Abstract available
     
     
     
104. PARTRIDGE AH
     Pregnancy after cancer: Timing is everything.
     Cancer. 2018 Nov 7. doi: 10.1002/cncr.31730.
     PubMed    
     
     
     
105. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
     Estimating child mortality associated with maternal mortality from breast and cervical cancer.
     Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
     PubMed     Abstract available
     
     
     October 2018
106. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
     Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
     Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
     PubMed     Abstract available
     
     
     
107. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
     Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
     Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
     PubMed     Abstract available
     
     
     
108. HOSKINS KF, Tejeda S, Vijayasiri G, Chukwudozie IB, et al
     A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
     Cancer. 2018 Oct 15. doi: 10.1002/cncr.31635.
     PubMed     Abstract available
     
     
     
109. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
     Weight loss and breast cancer incidence in postmenopausal women.
     Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
     PubMed     Abstract available
     
     
     September 2018
110. 
     Survivors of endometrial cancer are more likely to experience cardiovascular problems.
     Cancer. 2018;124:3633.
     PubMed    
     
     
     June 2018
111. ARMER JS, Clevenger L, Davis LZ, Cuneo M, et al
     Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.
     Cancer. 2018 Jun 15. doi: 10.1002/cncr.31570.
     PubMed     Abstract available
     
     
     May 2018
112. DUSKA LR
     Access to quality gynecologic oncology care: A work in progress.
     Cancer. 2018 May 16. doi: 10.1002/cncr.31391.
     PubMed    
     
     
     
113. SHALOWITZ DI, Huh WK
     Access to gynecologic oncology care and the network adequacy standard.
     Cancer. 2018 May 16. doi: 10.1002/cncr.31392.
     PubMed    
     
     
     
114. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
     Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
     Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
     PubMed     Abstract available
     
     
     March 2018
115. 
     Erratum: Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230-237.
     Cancer. 2018;124:1302.
     PubMed    
     
     
     
116. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
     Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
     Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
     PubMed     Abstract available
     
     
     February 2018
117. IYER NS, Cartmel B, Friedman L, Li F, et al
     Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity.
     Cancer. 2018 Feb 13. doi: 10.1002/cncr.31239.
     PubMed     Abstract available
     
     
     
118. PRINTZ C
     Abdominal fat linked to cancer risk in postmenopausal women.
     Cancer. 2018;124:449.
     PubMed    
     
     
     January 2018
119. LEVINE JM, Whitton JA, Ginsberg JP, Green DM, et al
     Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
     Cancer. 2018 Jan 16. doi: 10.1002/cncr.31121.
     PubMed     Abstract available
     
     
     
120. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
     Five-year relative survival for human papillomavirus-associated cancer sites.
     Cancer. 2018;124:203-211.
     PubMed     Abstract available
     
     
     December 2017
121. STEWART SL, Harewood R, Matz M, Rim SH, et al
     Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
     Cancer. 2017;123 Suppl 24:5138-5159.
     PubMed     Abstract available
     
     
     
122. BENARD VB, Watson M, Saraiya M, Harewood R, et al
     Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
     Cancer. 2017;123 Suppl 24:5119-5137.
     PubMed     Abstract available
     
     
     
123. PRINTZ C
     Women who undergo HPV testing receive earlier detection and treatment of cervical precancers.
     Cancer. 2017;123:4751.
     PubMed    
     
     
     
124. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
     Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
     Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
     PubMed     Abstract available
     
     
     
125. GROEN R, Abe K, Yoon HS, Li Z, et al
     Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.
     Cancer. 2017;125:918-925.
     PubMed     Abstract available
     
     
     November 2017
126. PRINTZ C
     Large population study quantifies chances of pregnancy after cancer treatment.
     Cancer. 2017;123:4308.
     PubMed    
     
     
     
127. LUTGENDORF SK, Thaker PH, Arevalo JM, Goodheart MJ, et al
     Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
     Cancer. 2017 Nov 7. doi: 10.1002/cncr.31078.
     PubMed     Abstract available
     
     
     October 2017
128. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
     Psychological distress associated with cancer screening: A systematic review.
     Cancer. 2017;123:3882-3894.
     PubMed     Abstract available
     
     
     
129. NELSON RA, Lai LL
     Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
     Cancer. 2017;123:4013-4021.
     PubMed     Abstract available
     
     
     September 2017
130. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
     The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
     Cancer. 2017 Sep 21. doi: 10.1002/cncr.30971.
     PubMed     Abstract available
     
     
     
131. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
     Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
     Cancer. 2017;123:3253-3260.
     PubMed     Abstract available
     
     
     August 2017
132. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
     Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
     Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
     PubMed     Abstract available
     
     
     
133. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
     Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
     Cancer. 2017;123:3080-3087.
     PubMed     Abstract available
     
     
     
134. HUNG YP, Lovitch SB, Qian X
     Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
     Cancer. 2017;125:604-614.
     PubMed     Abstract available
     
     
     July 2017
135. PRINTZ C
     Expert panel issues new global cervical cancer screening guideline.
     Cancer. 2017;123:2387-2388.
     PubMed    
     
     
     June 2017
136. GE Y, Christensen P, Luna E, Armylagos D, et al
     Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
     Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
     PubMed     Abstract available
     
     
     May 2017
137. GUO M, Khanna A, Wang J, Dawlett MA, et al
     Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
     Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
     PubMed     Abstract available
     
     
     
138. IVY SP, Kohn EC
     Drug development and registration: Challenges and opportunities in ovarian cancer.
     Cancer. 2017 May 12. doi: 10.1002/cncr.30645.
     PubMed    
     
     
     March 2017
139. SAMIMI G, Minasian LM
     Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
     Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
     PubMed    
     
     
     February 2017
140. ZANET E, Ciancia R, Michieli M, Tirelli U, et al
     "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
     Cancer. 2017;123:707-708.
     PubMed    
     
     
     
141. BENEDICT C, Thom B, Friedman DN, Diotallevi D, et al
     Reply to "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
     Cancer. 2017;123:708-709.
     PubMed    
     
     
     
142. JACKSON SE, Steptoe A, Fisher A
     Reply to Sexual quality of life in the cancer continuum.
     Cancer. 2017;123:530-531.
     PubMed    
     
     
     December 2016
143. GULATI R, Albertsen PC
     Insights from the PLCO trial about prostate cancer screening.
     Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: